← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2009Last known activity
Aug 31, 2018
Acquired by FSD Pharma on Oct 22, 2018
Timeline
2000s
- Jan 1, 2004
Therapix Biosciences Ltd.— Founded
2010s
- Oct 22, 2018
FSD Pharma— Acquired By
- Jul 23, 2019
Destiny Pharma Ltd— Acquired
Drugs by trial phase (9 distinct, 9 trials)
Phase 4 (0 own, 1 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 2 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (6)
- NCT03651726Lead sponsorPhase 2Aug 31, 2018
- NCT03646552Lead sponsorPhase 2Jun 4, 2018
- NCT03066193CollaboratorPhase 3Feb 1, 2017
- NCT01459419CollaboratorPhase 2Nov 1, 2011
- NCT01205087CollaboratorPhase 2Sep 1, 2010
- NCT00915187Lead sponsorPhase 2Oct 1, 2009
Details
- Founded
- Givatayim, IL Jan 1, 2004
- Last known activity
- Aug 31, 2018